PMGC Holdings shares are trading higher after the company announced its subsidiary, NorthStrive Biosciences, announced plans to initiated an independent flow cytometry analysis program to further characterize EL-22.

Benzinga Newsdesk www.benzinga.com Positive 94.4%

Neg 0% Neu 0% Pos 94.4%

Comments

No comments yet. Be the first!